Evidence map›Paper›PMID 33663550›Full record

ArticleOrphanet journal of rare diseases2021

HINT1 neuropathy in Norway: clinical, genetic and functional profiling.

Silvia Amor-Barris, Helle Høyer, Lin V Brauteset, Els De Vriendt, Linda Strand, Albena Jordanova, Geir J Braathen, Kristien Peeters

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disorders.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Silvia Amor-Barris *Molecular Neurogenomics Group, VIB-UAntwerp Center for Molecular Neurology, University of Antwerp, Unversiteitsplein 1, Building V, 2610, Antwerpen, Belgium.ORCID 0000-0001-9379-0563
Helle Høyer *Department of Medical Genetics, Telemark Hospital Trust, Sykehuset Telemark, Postboks 2900 Kjørbekk, 3710, Skien, Norway.ORCID 0000-0002-5445-0520
Lin V BrautesetDivision Elverum-Hamar, Department of Children and Youth, Innlandet Hospital Trust, Elverum, Norway.ORCID 0000-0002-4386-9641
Els De VriendtMolecular Neurogenomics Group, VIB-UAntwerp Center for Molecular Neurology, University of Antwerp, Unversiteitsplein 1, Building V, 2610, Antwerpen, Belgium.ORCID 0000-0002-1464-3846
Linda StrandDepartment of Medical Genetics, Telemark Hospital Trust, Sykehuset Telemark, Postboks 2900 Kjørbekk, 3710, Skien, Norway.ORCID 0000-0003-0530-9595
Albena Jordanova *Molecular Neurogenomics Group, VIB-UAntwerp Center for Molecular Neurology, University of Antwerp, Unversiteitsplein 1, Building V, 2610, Antwerpen, Belgium.ORCID 0000-0002-3833-3754
Geir J Braathen *Department of Medical Genetics, Telemark Hospital Trust, Sykehuset Telemark, Postboks 2900 Kjørbekk, 3710, Skien, Norway. geibra@stfh.no.ORCID 0000-0003-4703-9028
Kristien Peeters *Molecular Neurogenomics Group, VIB-UAntwerp Center for Molecular Neurology, University of Antwerp, Unversiteitsplein 1, Building V, 2610, Antwerpen, Belgium. Kristien.Peeters@uantwerpen.vib.be.ORCID 0000-0003-2202-3038
University of Antwerp · BETelemark Hospital · NOInnlandet Hospital Trust · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutosomal recessive axonal neuropathy with neuromyotonia has been linked to loss of functional HINT1. The disease is particularly prevalent in Central and South-East Europe, Turkey and Russia due to the high carrier frequency of the c.110G > C (p.Arg37Pro) founder variant.

resultsIn a cohort of 748 Norwegian patients with suspected peripheral neuropathy, we identified two seemingly unrelated individuals, compound heterozygous for a new variant (c.284G > A, p.Arg95Gln) and the most common pathogenic founder variant (c.110G > C, p.Arg37Pro) in the HINT1 gene. Probands presented with motor greater than sensory neuropathy of various onset, accompanied by muscle stiffness and cramps in the limbs. Furthermore, they displayed non-classical symptoms, including pain in the extremities and signs of central nervous system involvement. Haplotype analysis in both patients revealed a common chromosomal background for p.Arg95Gln; moreover, the variant was identified in Swedish carriers. Functional characterization in HINT1-knockout and patient-derived cellular models, and in HNT1-knockout yeast, suggested that the new variant is deleterious for the function of HINT1 and provided mechanistic insights allowing patient stratification for future treatment strategies.

conclusionOur findings broaden the genetic epidemiology of HINT1-neuropathy and have implications for molecular diagnostics of inherited peripheral neuropathies in Scandinavia.

Indexed as

Charcot-Marie-Tooth DiseaseNerve Tissue ProteinsPeripheral Nervous System DiseasesEuropeHumansMutationNorwayTurkeyHINT1 protein, humanNerve Tissue ProteinsCharcot-Marie-Tooth diseaseHINT1NeuromyotoniaNorwayPeripheral neuropathy

Identifiers

PMID33663550
PMCPMC7934415
OpenAlexW3133735390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.